The ESG develops a free of charge online updating program for women’s health HCPs.
Each month 2 keynote speakers will discuss on a range of topics devoted to improving your knowledge and professional development in your daily clinical practice.
Additionally, you will have the opportunity to participate in live question and answer sessions.These monthly resources provide you with invaluable and engaging insights covering a wide spectrum of subjects, including Breast Cancer, IVF, Pregnancy, Hypotalamic Amenorrhea, Gynecologial Oncology, Genital Infections and many others.
To access the library of on-demand webinars available anytime, please click on “Past webinars”.
Gynecology & Obstetrics
2 speakers each month
Time for Q&A
UPCOMING WEBINARS
PAST WEBINARS
UPCOMING WEBINARS
Prof. Andrea Giannini
Chairman
Chairman
Prof. Angelos Daniilidis 
Sentinel node modern practice in endometrial cancer
Sentinel node modern practice in endometrial cancer
Prof. Ioannis Kalogiannidis
Early stage cervical cancer and developments in fertility practice
Early stage cervical cancer and developments in fertility practice
Prof. Kimon Chatzistamatiou
Frontiers of conservative approach of Borderline tumors
Frontiers of conservative approach of Borderline tumors
Prof. Raoul Orvieto
Chairman
Chairman
Prof. Raoul Orvieto
Fresh vs Freeze all cycles- When and to Whom?
Fresh vs Freeze all cycles- When and to Whom?
Prof. Ariel Weissman
Optimizing frozen-thawed embryo transfer protocols
Optimizing frozen-thawed embryo transfer protocols
Prof. Nathalie Chabbert-Buffet
Chairman
Chairman
Prof. Mark Brincat 
Therapeutic protocols including the use of GLP-1 receptor agonist
Therapeutic protocols including the use of GLP-1 receptor agonist
Second Speaker TBD
Prof. Andrea Genazzani
Chairman
Chairman
Prof. Blazej Meczekalski 
Pathophysiology and long-term consequences of Functional Hypothalamic Amenorrhea
Pathophysiology and long-term consequences of Functional Hypothalamic Amenorrhea
Prof. Alessandro Genazzani
Complementary treatments and low dose estrogens as treatments for Functional Hypothalamic Amenorrhea (FHA)
Complementary treatments and low dose estrogens as treatments for Functional Hypothalamic Amenorrhea (FHA) PAST WEBINARS
Prof. Stefano Angioni
Chairman
Chairman
Prof. Angelos Daniilidis
Surgical treatments of ovarian endometriomas
Surgical treatments of ovarian endometriomas
Prof. Mohamed Mabrouk 
Deep Endometriosis Surgery: What you need to know
Deep Endometriosis Surgery: What you need to know
Dr. Alin Constantin
Ultrasonography for the diagnosis endometriosis as a first line approach
CoriolusVersicolor-based Vaginal Gel. What is new? Latest clinical evidence
29-Jan 15:00–16:15
Prof. Andrea Genazzani
Chairman
Chairman
Prof. Filippo Murina
HPV Infection: Understanding Its Natural History and Implications for Prevention and Care
HPV Infection: Understanding Its Natural History and Implications for Prevention and Care
Dr. Luis Serrano 
Enhancing HPV Clearance with a CoriolusVersicolor-based vaginal gel
Enhancing HPV Clearance with a CoriolusVersicolor-based vaginal gel 
Prof. Andrea Genazzani
Chairman
Chairman
Prof. Andrea Giannini
Intercepting endometrial cancer risk factors across the women’s life
Intercepting endometrial cancer risk factors across the women’s life
Dr. Francesco Multinu and Dr. Ida Pino
Conservative treatment of endometrial preneoplastic and neoplastic diseases in fertile women
Conservative treatment of endometrial preneoplastic and neoplastic diseases in fertile women 
Prof. Andrea Genazzani
Chairman
Chairman
Prof. Jonathan Douxfils 
The normalized Activated Protein C sensitivity ratio (nAPCsr): the INR of the gynecologist for a safer prescription of estrogen-containing products
The normalized Activated Protein C sensitivity ratio (nAPCsr): the INR of the gynecologist for a safer prescription of estrogen-containing products
Prof. Nathalie Chabbert-Buffet
DVT in Contraception
DVT in Contraception 
Prof. Andrea Genazzani
Chairman
Chairman
Prof. Pedro Barri
Embryo mosaicism. Basis and clinical decisions
Embryo mosaicism. Basis and clinical decisions
Prof. Ana Teresa Almeida Santos 
Fertility preservation in Ovarian Cancer
Fertility preservation in Ovarian Cancer 
Prof. Andrea Genazzani
Chairman
Chairman
Prof. Blazej Meczekalski
Challenges in diagnosis and long-term consequences on FHA
Challenges in diagnosis and long-term consequences on FHA
Prof. Alessandro Genazzani
Treatment approach to FHA
Treatment approach to FHA 
Prof. Kristina Gemzell-Danielsson
Chairman
Chairman
Prof. Kristina Gemzell-Danielsson
Compliance for real-life effectiveness
Compliance for real-life effectiveness
Prof. Franca Fruzzetti
Woman and the right estrogen – an indissoluble combination in contraception
Woman and the right estrogen – an indissoluble combination in contraception
Prof. Terhi Piltonen 
Insights from the estetrol/drospirenone clinical trials
Insights from the estetrol/drospirenone clinical trials
Prof. Jonathan Douxfils
Hemostasis parameters with estetrol/drospirenone – why APC resistance matters
Hemostasis parameters with estetrol/drospirenone – why APC resistance matters
Prof. Tommaso Simoncini
A new horizon in combined hormonal contraception and beyond
A new horizon in combined hormonal contraception and beyond 
Prof. Paolo Mannella
Chairman
Chairman
Prof. Pavel Calda 
Diagnostic and management of PAS
Diagnostic and management of PAS
Prof. Frederic Chantraine
How to prepare for Delivery
How to prepare for Delivery 
Prof. Antonio Cano
Chairman
Chairman
Prof. Andrzej Milewicz
Metabolic diseases and Menopause
Metabolic diseases and Menopause
Prof. Alfred Mueck 
Individualized MHT to optimise vascular and metabolic effects
Individualized MHT to optimise vascular and metabolic effects